Aspiriant LLC’s Nuveen ESG Emerging Markets Equity ETF NUEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Hold
9,622
0.01% 275
2026
Q1
$354K Hold
9,622
0.01% 254
2025
Q4
$342K Hold
9,622
0.01% 258
2025
Q3
$343K Hold
9,622
0.01% 235
2025
Q2
$320K Hold
9,622
0.01% 243
2025
Q1
$281K Hold
9,622
0.01% 244
2024
Q4
$279K Sell
9,622
-1,046
-10% -$31.9K 0.01% 241
2024
Q3
$331K Hold
10,668
0.01% 224
2024
Q2
$306K Buy
+10,668
New +$298K 0.01% 225

Other funds holding NUEM

Aspiriant LLC's NUEM Position: Q2 2026 in Review

Aspiriant LLC held its Nuveen ESG Emerging Markets Equity ETF (NUEM) position steady in Q2 2026 at 9,622 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #275.

Aspiriant LLC first reported a position in NUEM in Q2 2024 and has held it in 9 quarters since. 119 funds tracked by Wall St. Rank hold NUEM as of Q2 2026.

  • Aspiriant LLC held 9,622 shares of Nuveen ESG Emerging Markets Equity ETF worth $408K as of Q2 2026.
  • Aspiriant LLC left its Nuveen ESG Emerging Markets Equity ETF share count unchanged in Q2 2026.
  • Nuveen ESG Emerging Markets Equity ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #275 holding.
  • Aspiriant LLC first reported a position in Nuveen ESG Emerging Markets Equity ETF in Q2 2024 and has held it in 9 quarters since.
  • 119 funds tracked by Wall St. Rank held Nuveen ESG Emerging Markets Equity ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.